Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co LtdfiledCriticalYamanouchi Pharma Co Ltd
Priority to FI853574ApriorityCriticalpatent/FI83516C/fi
Publication of FI853574A0publicationCriticalpatent/FI853574A0/fi
Publication of FI853574LpublicationCriticalpatent/FI853574L/fi
Publication of FI83516BpublicationCriticalpatent/FI83516B/fi
Application grantedgrantedCritical
Publication of FI83516CpublicationCriticalpatent/FI83516C/fi
2,6-Diméthyl-4-(2,3-dichlorophenyl)-1,4-dihydropyridine-3,5-dicarboxylique acide,3-méthyl ester 5-ethylester à activité hypotensive son procédé de préparation et compositions pharmaceutiques le contenant
Toepassing van 1,4-dihydro-2,6-dimethyl-4-(3-nitrofenyl)pridine-3-beta-methoxy-ethylester-5-isopropylester ter bereiding van cerebral werkzame geneesmiddelen.
Un procedimiento para la preparacion del diastereomero a de 2,6-dimetil-4-(m-nitrofenil)-1,4-dihidropiridin-3,5-dicarboxilato de 3-(1-bencilpirrolidin-3-ilo) y 5-metilo
Fremg.maate for fremst. av den hoeyredreiende, optiske isomer av diastereomer a av ym-09730, med kjem. navn (+)-2,6-dimethyl-4-(n-nitrofenyl)-1,4-dihydropyridin-3,5-dicarboxylsyre-3-(1-benzylpyrrolidin-3-yl)-ester-5-methylester.
Verfahren zur herstellung von pharmazeutischen zusammensetzungen mit kontrollierter freisetzung eines 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro- 2,6-dimethyl-3,5-pyridindicarboxylatester- wirkstoffes
Process for the preparation of esters of the 1,4-dihydro-2,6-dimethyl-3-(alcoxicarbonyl or alcoxialcoxicarbonyl)-4-(substituted phenyl) pyridin-5-carboxylic acid of stereochemical isomers and pharmaceutically acceptable salts thereof